Could a blood clot improve penile surgery in boys?

NCT ID NCT07319780

Recruiting now Disease control Sponsor: National Children's Medical Center, Uzbekistan Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two surgical techniques for correcting a common birth defect in boys where the urine opening is on the underside of the penis. One method uses a graft from tissue, while the other uses a special membrane made from the patient's own blood (platelet-rich fibrin) to help healing. The goal is to see which approach leads to fewer complications like fistulas or narrowing of the opening. The trial will involve 100 boys aged 6 months to 7 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous platelet-rich fibrin membrane
What this could lead to: If it works, this could offer a safer, more effective surgical technique for boys with hypospadias, reducing the need for follow-up procedures.
What could go wrong: This is a relatively small, early-stage trial (100 participants) comparing two surgical methods. The benefit of platelet-rich fibrin is not yet proven, and surgical outcomes can vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISTAL HYPOSPADIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypospadias

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DISTAL HYPOSPADIAS HYPOSPADIAS

Contacts and locations

Locations

Dr. Cipto Mangunkusumo Hospital
NOT_YET_RECRUITING

Jakarta, DKI Jakarta, 10430, Indonesia
National Children's Medical Center
RECRUITING

Tashkent, Tashkent, 100020, Uzbekistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.